What is TTRX's price / book?

TTRX (TTRX) reported price / book of 15.4× in Q1 2026.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

TTRX TTRX Price / book

Price / book at other companies

Regeneron PharmaceuticalsREGN

2.6×+0.2×

Journey Medical CorporationDERM

4.2×-2.2×

PTH

Pelthos Therapeutics Inc.PTHS

2×—

Celldex TherapeuticsCLDX

4.6×+2.9×

Arcutis Biotherapeutics, Inc.ARQT

15.4×+2.4×

Kymera TherapeuticsKYMR

4.4×+2.2×

Other financials

Income statement

See full

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

See full

Operating cash flow-$1.6M-448%

Valuation

See full

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

See full

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Where this comes from

Calculated from TTRX’s reported figures.

market cap/total stockholders equity=15.4×

Based on the most recent quarter.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's price / book?: TTRX (TTRX) reported price / book of 15.4× in Q1 2026.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.